← Melatonin

Beyond Sleep

Melatonin is a powerful antioxidant and immune modulator, not just a sleep hormone -- and most people are taking too much.

Most people know melatonin as a sleep supplement, but that undersells it dramatically. Melatonin is one of the most potent antioxidants your body produces, it modulates immune function, and it has been studied as an adjunct in cancer treatment. It is produced in the pineal gland, the gut, the retina, and the bone marrow -- your body makes it in far more places than just the brain [1].

The irony is that the typical supplement dose (5-10mg) may actually be counterproductive compared to much lower amounts.

A potent antioxidant, not just a hormone

Melatonin is a direct free radical scavenger that neutralizes hydroxyl radicals, hydrogen peroxide, singlet oxygen, and peroxynitrite [1]. Unlike most antioxidants that donate one electron per molecule, melatonin triggers an antioxidant cascade -- its metabolites (cyclic 3-hydroxymelatonin, AFMK, AMK) are themselves antioxidants, meaning a single melatonin molecule can scavenge up to 10 reactive oxygen species [1]. Reiter et al. described this as melatonin "under-promising but over-delivering" as an antioxidant.

Melatonin also upregulates endogenous antioxidant enzymes including glutathione peroxidase, superoxide dismutase, and catalase, while downregulating pro-oxidant enzymes like nitric oxide synthase [2]. This dual action -- direct scavenging plus enzyme regulation -- makes it uniquely effective.

Immune modulation

Melatonin acts as an immunomodulator rather than a simple immune stimulant. It enhances the production of natural killer cells, T-helper cells, and immunoglobulins during immune challenge, while also having anti-inflammatory properties that help prevent excessive immune responses [2]. This balance is why melatonin has been investigated in contexts ranging from infection response to autoimmune conditions. Carrillo-Vico et al. (2005) described melatonin as an "immune buffer" that amplifies immunity when needed and dampens it when overactivated [2].

Cancer research

Melatonin has shown anti-tumor activity in both in vitro and animal studies, particularly in hormone-dependent cancers. Hill et al. (2015) reviewed the evidence on breast cancer, finding that melatonin suppresses tumor growth through multiple mechanisms: inhibiting estrogen receptor signaling, reducing aromatase activity, modulating epigenetic pathways, and enhancing the cytotoxicity of chemotherapy drugs [4]. Night-shift workers, who have chronically suppressed melatonin due to light exposure at night, have consistently higher rates of breast and prostate cancer -- a relationship strong enough that the WHO classified night-shift work as a probable carcinogen (Group 2A).

Dosing: less is more

This is where most people go wrong. Over-the-counter melatonin supplements typically come in 3mg, 5mg, or 10mg doses, but research suggests that physiological doses of 0.3-0.5mg are often more effective for sleep than these supraphysiological amounts [3]. Lewy et al. found that low doses entrained circadian rhythms more effectively than high doses. Higher doses can cause morning grogginess, vivid dreams, and -- critically -- may desensitize melatonin receptors over time, potentially reducing your body's natural melatonin response.

Long-term supplementation at high doses may downregulate natural pineal production. If you do supplement, start with the lowest dose available (0.3-0.5mg), taken 30-60 minutes before your target bedtime.

Blue light destroys melatonin production

Your pineal gland produces melatonin in response to darkness. Blue light (460-480 nm wavelength) -- the dominant spectrum emitted by phones, tablets, and LED screens -- is the most potent suppressor of melatonin synthesis. Even moderate blue light exposure in the two hours before bed can delay melatonin onset by 90 minutes or more. This is covered in depth in the Sleep section on blue light and circadian rhythm.

Food sources of melatonin

Several foods contain meaningful amounts of melatonin:

  • Tart cherries -- the richest known food source, particularly Montmorency cherries. Tart cherry juice concentrate has been shown in clinical trials to modestly improve sleep duration and quality.
  • Pistachios -- contain exceptionally high levels of melatonin (about 660 ng/g), far more than most other nuts.
  • Walnuts, almonds, and flaxseeds -- contain moderate amounts.
  • Tomatoes, peppers, and mushrooms -- contain smaller but measurable quantities.

Getting melatonin from food delivers it in physiological doses alongside cofactors, which may be preferable to isolated supplements for general health maintenance.

Timing matters

Melatonin's effectiveness depends heavily on when you take it. For sleep, take it 30-60 minutes before your intended bedtime. Taking it too early can shift your circadian rhythm earlier than desired; taking it too late means it hasn't reached peak levels by the time you want to fall asleep. For circadian rhythm disorders (jet lag, shift work), the timing protocol is different and depends on the direction of the desired shift.

Antioxidant cascade mechanism

Reiter et al. (2001) detailed the "antioxidant cascade" unique to melatonin [1]. Unlike conventional antioxidants like vitamin C or E, which become pro-oxidant after donating an electron, melatonin's metabolites retain antioxidant activity. The cascade proceeds: melatonin scavenges a hydroxyl radical to form cyclic 3-hydroxymelatonin (c3OHM), which itself scavenges additional radicals to form N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK), which further scavenges to form N1-acetyl-5-methoxykynuramine (AMK). Each product in the cascade is an effective antioxidant, meaning one melatonin molecule can neutralize up to 10 reactive oxygen and nitrogen species. This efficiency is orders of magnitude greater than that of glutathione or vitamin C on a per-molecule basis.

Immune buffering

Carrillo-Vico et al. (2005) reviewed melatonin's immunomodulatory role across multiple immune cell types [2]. In immunosuppressed states, melatonin enhanced T-helper cell proliferation, increased IL-2 and IFN-gamma production, and stimulated natural killer cell activity. In inflammatory conditions, melatonin reduced pro-inflammatory cytokines (TNF-alpha, IL-6, IL-8) and inhibited NF-kB activation. The authors proposed that melatonin acts through specific membrane receptors (MT1 and MT2) on immune cells and through receptor-independent intracellular mechanisms, functioning as an immune system modulator that adjusts responses based on context rather than simply upregulating or downregulating immunity.

Low-dose superiority for circadian entrainment

Lewy et al. (2002) studied a blind individual with a free-running circadian period of 24.9 hours [3]. They administered melatonin at doses of 0.5mg, 5mg, and 20mg. The 0.5mg dose successfully entrained the circadian rhythm, while the higher doses did not -- they appeared to overwhelm melatonin receptors and produce a flattened dose-response curve. This finding supported the concept that melatonin's chronobiotic (clock-setting) effect operates through receptor-mediated pathways that saturate at low concentrations, meaning that higher doses can actually be less effective than physiological doses for circadian rhythm management.

Melatonin and hormone-dependent cancers

Hill et al. (2015) reviewed two decades of research on melatonin's oncostatic effects in breast cancer [4]. Key findings included: melatonin suppresses estrogen receptor alpha (ERα) transcriptional activity via the MT1 receptor; it inhibits aromatase expression in breast adipose tissue, reducing local estrogen synthesis; and it enhances the anti-proliferative effects of tamoxifen and other anti-estrogen therapies. Animal studies demonstrated that constant light exposure (which suppresses melatonin) accelerated tumor growth, while melatonin supplementation reversed this effect. The epidemiological evidence from night-shift worker studies provided human-level support, with meta-analyses showing a 40-60% increased breast cancer risk in long-term night-shift workers who experience chronic melatonin suppression.

References

  1. Melatonin as an antioxidant: under promises but over deliversReiter RJ, Tan DX, Manchester LC, Qi W. Journal of Pineal Research, 2001. PubMed 16687048 →
  2. Melatonin in the promotion of healthCarrillo-Vico A, Guerrero JM, Lardone PJ, Reiter RJ. Journal of Pineal Research, 2005. PubMed 15649736 →
  3. Low, but not high, doses of melatonin entrained a free-running blind person with a long circadian periodLewy AJ, Emens JS, Sack RL, Hasler BP, Bernert RA. Chronobiology International, 2002. PubMed 7581063 →
  4. Melatonin: an anti-tumor agent in hormone-dependent cancersHill SM, Belancio VP, Dauchy RT, Xiang S, Brimer S, Mao L, Hauch A, Lundberg PW, Summers W, Yuan L, Frasch T, Blask DE. International Journal of Endocrinology, 2015. PubMed 30036891 →

Weekly Research Digest

Get new topics and updated research delivered to your inbox.